u/honest_syringe_pls

I would not read a single slow shipment as a lane change. Post it and let the median move if it is real.

That is the quoted lead time, not the observed transit. Both belong in the report and they are different columns.

Same lane in a different season for comparison?

Not convinced by four data points. That is not a lane yet, it is an anecdote with a route attached.

Push back: comparing a July transit with a February one on the same lane is not a comparison.

Resolution between two peaks depends on retention, selectivity and efficiency. A shallower gradient buys retention and usually resolution, at the cost of peak width and run time.

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

Cosigning on the glucagon arm. It is the mechanistic thread that connects the hepatic and the metabolic effects.

Not convinced. Imaging-based fat fraction is not the same as a histological response and the paper is explicit about that.

Same method at both labs, or two different gradients?

Annotation is what makes a log survive contact with your future self. A single note beside an unusual week saves an hour of puzzled reconstruction later.

two identical orders a week apart is the cheapest experiment available

Did you run a blank between injections?

Agreed. And the corollary is that the method line on a certificate is not decoration, it is the number’s provenance.

That is an escalation schedule for an unapproved compound and this board does not host those.

Reading a trace posted here, in the order I actually look at things.

Axes first — if the wavelength and the time axis are not labelled, I stop. Then the baseline: where has it been drawn, and does the drawing absorb anything. Then peak shape: fronting, tailing, a shoulder that never resolves. Then the blank, if one was run, for carryover.

Only after all of that do I look at the percentage, and by then I usually know how much weight it deserves. The number is the last thing on the page and the first thing everybody argues about, which is exactly backwards.

Do you have the mass, or only the UV trace?

a lane with four reports is not yet a lane

This is why the lane table is organised the way it is. The supplier is not the unit.

Disagree — that is a weight endpoint from a different programme and you are quoting it in a hepatic context.

Right. And a blank between injections settles the carryover argument before it starts.

Phase 2 in a biopsy-confirmed population is a demanding design: recruitment is slow, the population is specific, and the results do not generalise to

Agreed — and the endpoint definitions are where the actual claim lives.

axis labels or the trace is decoration

Small fix — that is a reconstructed entry rather than a contemporaneous one, and the post presents it as the latter.

Why two honest labs report different numbers on the same vial.

Start with the gradient. A shallower slope holds compounds on the column longer and usually separates close-eluting species better. A steeper one gets you a faster run and a fatter peak. If a related substance elutes near the main peak, one method resolves it and reports it separately, the other absorbs part of it into the main peak.

Then integration. Where the baseline is drawn under a shoulder is a decision made by a person or by a piece of software configured by a person. It moves the number.

A point or two of spread between services on this assay is ordinary. Treating one lab as ground truth is how people end up in arguments with suppliers that neither side can win.

Push back: a longer run is not automatically better resolution. You are trading peak width for time and the ratio is what matters.

Same. Very thin independent data on this one, which should make everybody here more tentative than they are.

Why contemporaneous beats reconstructed, with the failure mode.

This is the whole discipline in one line. Contemporaneous, consistent, minimal.

Are the missed weeks in there as blanks or dropped entirely?

Reconstructed six weeks from memory once and later found receipts that contradicted my own log. Never again.

Carryover from a previous high-concentration injection looks exactly like a small impurity. The blank injection is four minutes and it removes the ambiguity entirely.

the last mile is where most of the variance lives

Disagree. That is a customs hold, not a carrier delay, and lumping them together makes the lane table wrong.

The attribution problem, which is the reason most logs on this board cannot answer the question their owner is asking.

If dose, training, intake and sleep all changed in the same fortnight, no analysis of the resulting numbers can tell you which one moved the outcome. That is not a limitation of your spreadsheet; it is a limitation of the design.

The fix is unglamorous: change one thing at a time, leave it long enough to see, and annotate the weeks where something else intruded anyway — because life will intrude. A log with honest annotations answers questions. A log with four simultaneous changes and a confident conclusion is the most common thing posted here, and it does not.

Why this board reports by lane and not by supplier.

Two members ordering from the same operation, in the same month, can see completely different transit times because they are on different routes with different carriers and different clearance points. Averaging them produces a supplier-level number that predicts nothing for either of them.

A lane — origin, destination, carrier, month — is the smallest thing that behaves consistently enough to be worth measuring. Once a route has a dozen reports behind it the median is genuinely useful, and that is what the tables on the source pages are built from.

The system suitability argument, since it comes up whenever somebody posts a number without one.

Before the sample result means anything, the instrument has to be shown to be fit that day: replicate injections with an acceptable RSD on area, a tailing factor inside limits, adequate plate count, and a resolution check between the pair you care about.

None of that is exotic and all of it is routine in a laboratory that reports for a living. Its absence does not mean a number is wrong; it means the number is unanchored, and unanchored numbers should not be quoted to two decimal places on this board.

That is area percent, not mass percent. The trace cannot give you the second one.

Correction: that was clearance time, not carrier time. The lane table separates them for exactly this reason.

Did you run a blank between injections?

Started reporting my own integrations with the baseline choice stated. Arguments in my threads dropped by about half.